Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 677

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 11
Chunk 677
---
 Capital the right to
lend to the Company up to an additional $7.7 million, on substantially the same terms as the prior loans, through December 31, 2024.
On or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”),
pursuant to which DBR Capital has been given until August 31, 2025 to lend to the Company a minimum of $2.0 million, and until December
31, 2026 to lend to the Company the balance of up to $5.7 million. The Amendment also substantially reduces the interest rate for the
first $2 million that may be advanced by DBR Capital from 38.5% to 18.75% per annum, and further substantially reduces the interest rate
to 10% per annum (also from 38.5%) for any amounts loaned in excess of $2 million. Funding of the additional loan amounts remain at the
sole discretion of DBR Capital as the Company has no right to call the loan amounts. In electing to enter into the Amendment, which was
approved by the disinterested members of our board of directors, we took into consideration, among other things, the avoidance of additional
interest charges under the current lending arrangement that we would have been caused to incur in the immediate term were DBR Capital
to have put the additional loans to the Company during December 2024, as well as our need for expansion capital in the future.

41

Messrs.
Rothrock and Bell were appointed as DBR Capital’s designees to our Board of Directors pursuant to the April 2020 Securities Purchase
Agreement. The Securities Purchase Agreement and related transaction documents, as amended in November 2020, among other things, expanded
our Board of Directors to seven members, leaving two seats vacant, and granted DBR Capital the right to fill those vacancies and remove
directors in the event of default under the transaction documents.

Separation,
Stock Purchase, and Release Agreements with Two Former Officers and Directors

On
September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase
and Release Agreement, dated September 18, 2023 (the “2023 Agreement”). Under the 2023 Agreement, the Company purchased for
surrender in a series of private transactions, an aggregate of